Portfolio

      Therapeutic areas with gigantic medical needs as well as big market potential

      Oblique Therapeutics currently has eleven programs in the pipeline with a focus on pain and aggressive-metastatic cancer. Four current programs are being developed in collaboration with leading pharmaceutical companies.